Safety

Bronopol Nitrosamine Formation Risk: Mechanism & Control

Nitrosamine formation is the single most important formulation risk associated with Bronopol and the primary reason some markets restrict its cosmetic use. This guide explains the chemistry, why Bronopol itself is not a nitrosating agent, and how formulators control the risk in practice.

Published 2026-01-20Updated 2026-07-27By Vasudev Chemo Pharma Technical TeamReviewed by Vasudev Chemo Pharma EHS & Quality Team, Industrial Safety, GHS Classification

Is Bronopol Itself a Nitrosating Agent?

No. Bronopol is not itself a nitrosating agent. However, under conditions where it decomposes — alkaline solution and/or elevated temperature — it can liberate nitrite ions and low levels of formaldehyde, and these decomposition products can react with contaminant secondary amines or amides to form nitrosamines.

The distinction matters for risk communication: Bronopol does not directly nitrosate amines the way a true nitrosating agent would. Instead, its decomposition under specific conditions releases nitrite, which is the reactive species capable of forming nitrosamines when it encounters a secondary amine or amide contaminant elsewhere in the formulation. Because nitrosamine formation requires both Bronopol decomposition (releasing nitrite) and the presence of a secondary amine or amide, controlling either factor — formulation pH/temperature stability or raw material purity — substantially reduces the risk.

What Conditions Increase Nitrosamine Formation Risk?

Alkaline pH and elevated temperature accelerate Bronopol decomposition and nitrite release. The presence of secondary amines or amides — even as trace contaminants in other raw materials — is the second required condition for nitrosamine formation to occur.

Formulations most at risk combine an alkaline or near-alkaline pH, storage or processing at elevated temperature, and raw materials (surfactants, conditioning agents, fragrance components) that may carry trace secondary amine or amide contamination from their own manufacturing process, even if not intentionally added. Due to the toxicity of nitrosamines, "significant" formation is considered to occur at levels as low as tens of parts per billion, meaning even trace-level contamination combined with decomposition conditions is a genuine formulation risk that regulatory authorities and formulators actively manage.

How Do Formulators Control Nitrosamine Formation Risk?

Manufacturers are instructed by regulatory authorities to avoid nitrosamine formation by removing amines or amides from the formulation where possible, removing Bronopol from formulations with amine/amide risk, or using nitrosamine inhibitors. Raw material screening for secondary amine contamination is standard practice.

Practical control measures include: sourcing raw materials with verified low secondary amine/amide content, maintaining formulation pH on the acidic side of neutral to slow Bronopol decomposition, avoiding elevated processing and storage temperatures where possible, and using established nitrosamine inhibitors in formulations where amine-containing raw materials cannot be avoided. Cosmetic raw materials that may contain trace amounts of secondary amines or amides should undergo thorough cleaning and strict control before use in Bronopol-containing formulations. Some markets, including Canada, have introduced specific compositional and product restrictions on Bronopol use as a result of this risk, and formulators exporting to multiple markets should confirm current restrictions for each target country.
Nitrosamine formation risk factors and mitigation approaches
Risk factorEffectMitigation
Alkaline pHAccelerates Bronopol decomposition, nitrite releaseFormulate on the acidic side of neutral where possible
Elevated temperatureAccelerates decomposition rateAvoid unnecessary heat during processing and storage
Secondary amine/amide contaminationReacts with released nitrite to form nitrosaminesScreen and specify low-amine raw materials
Prolonged storageMore time for decomposition and reaction to occurMonitor shelf-life stability data for nitrosamine formation

Frequently asked questions

Does Bronopol always form nitrosamines?+
No. Nitrosamine formation requires both Bronopol decomposition (releasing nitrite, favoured by alkaline pH and heat) and the presence of a secondary amine or amide contaminant. Formulations without amine-containing raw materials, and maintained at acidic-to-neutral pH, carry substantially lower risk.
Why has Canada restricted Bronopol in cosmetics?+
Canada has introduced compositional and product restrictions on Bronopol use in certain cosmetic categories in response to nitrosamine formation risk. Confirm current Canadian regulatory requirements for your specific product category before formulating for that market.
Can nitrosamine formation with Bronopol be completely prevented?+
Risk can be substantially reduced through raw material screening for secondary amines/amides, maintaining acidic-to-neutral formulation pH, avoiding elevated temperatures, and using nitrosamine inhibitors where amine-containing materials cannot be avoided — but formulators should treat this as an ongoing risk management practice, not a one-time check.
What is a 'significant' level of nitrosamine contamination?+
Due to nitrosamine toxicity, levels as low as tens of parts per billion are considered significant in regulatory risk assessments. This is why even trace-level secondary amine contamination in raw materials is treated seriously in Bronopol-containing formulations.

Sources

  1. PubChem — Bronopol compound summary
  2. European Chemicals Agency — Cosmetics preservatives list (CosIng)